Skip to content

Sun Pharma slips 3% on production halt at Mohali unit for corrective actions

JP Morgan sees a limited 1-2 percent impact on Sun Pharma#39;s FY24 earnings due to the production halt.

Read More

​ JP Morgan sees a limited 1-2 percent impact on Sun Pharma#39;s FY24 earnings due to the production halt. JP Morgan sees a limited 1-2 percent impact on Sun Pharma#39;s FY24 earnings due to the production halt.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish